Indeed, consistent with the idea of targeting ER redox proteins in disease, high-throughput drug screens have identified potent inhibitors of human PDI in an effort to combat upregulation that is associated with some cancers and neurodegenerative diseases [35–38]. The gene discussed is P4HB; the disease is cancer.